Studies related to Verbal Fluency and Ginkgo biloba

Ginkgo Biloba Extract EGb 761(R), Donepezil Or Both Combined In The Treatment Of Alzheimer's Disease With Neuropsychiatric Features: A Randomised, Double-blind, Exploratory Trial

Effect Increase
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 96
Sex Both Genders
Age Range 45-64, 65+
Notes for this study:
EGb-761 appears to be equally effective as Donezepil in reducing cognitive impairment associated with Alzheimer's, although combination therapy was more effective than either in isolation.

Full details on all 2 studies are available to Examine memberstry free for 7 days.

Already a member? Log in now to access.